Medicare Enrolled
Dr. Saumilkumar Karavadia, MD
Urology Physician · Oxford, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Karavadia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Karavadia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Karavadia
Dr. Saumilkumar Karavadia is an urology physician in Oxford, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Karavadia performed 17,006 Medicare services across 5,686 unique beneficiaries.
Between the years covered by Open Payments, Dr. Karavadia received a total of $47,763 from 62 pharmaceutical and/or device companies across 590 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Karavadia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 7% volume in FL
$47,763 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,006
Medicare services
Top 7% in FL for urology physician
5,686
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~945 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,501 | $0 | $1 |
| BCG treatment for bladder cancer | 3,250 | $2 | $5 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
2,563 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,678 | $92 | $320 |
| Leuprolide injectable, camcevi, 1 mg | 966 | $68 | $130 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
879 | $8 | $26 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
809 | $6 | $6 |
| Gadolinium MRI contrast injection Administration of a gadolinium-based contrast agent to enhance magnetic resonance imaging. The dose is measured per milliliter of the agent injected. |
747 | $1 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
635 | $64 | $227 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
379 | $47 | $159 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
249 | $117 | $422 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
247 | $21 | $60 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
210 | $61 | $610 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 161 | $136 | $336 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
78 | $64 | $219 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
76 | $24 | $81 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
55 | $44 | $156 |
| MRI of pelvis with and without contrast A magnetic resonance imaging scan of the pelvic area performed both before and after the administration of a contrast dye to enhance image detail. |
48 | $125 | $354 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
48 | $76 | $216 |
| MRI of abdomen with and without contrast An MRI scan of the abdomen using contrast dye before and after administration to create detailed images of internal structures. |
46 | $147 | $386 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
42 | $195 | $527 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
37 | $134 | $599 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
36 | $115 | $809 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
34 | $325 | $1,061 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
30 | $64 | $179 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
29 | $16 | $57 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $104 | $341 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
26 | $443 | $1,460 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
22 | $584 | $1,866 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
20 | $26 | $93 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
18 | $223 | $735 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
16 | $138 | $992 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $106 | $612 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $87 | $283 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
13 | $118 | $798 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
31.9% medium
67.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,763
Total received (2018-2024)
Avg $6,823/year across 7 years
Top 6% in FL for urology physician
62
Companies
590
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$32,656 (68.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,512 (28.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,596 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,289
2023
$7,113
2022
$10,423
2021
$2,148
2020
$8,019
2019
$4,608
2018
$7,165
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$29,059
PFIZER INC.
$4,595
Intuitive Surgical, Inc.
$1,901
Astellas Pharma Global Development
$1,596
Janssen Biotech, Inc.
$1,292
Myriad Genetic Laboratories, Inc.
$1,250
Medtronic USA, Inc.
$1,004
Bayer Healthcare Pharmaceuticals Inc.
$616
Sumitomo Pharma America, Inc.
$592
Axonics, Inc.
$387
AstraZeneca Pharmaceuticals LP
$377
Teleflex LLC
$320
Endo Pharmaceuticals Inc.
$303
Myovant Sciences Inc.
$292
UROVANT SCIENCES INC
$261
UROGEN PHARMA, INC.
$247
ABBVIE INC.
$244
Dendreon Pharmaceuticals LLC
$239
Novartis Pharmaceuticals Corporation
$225
Bayer HealthCare Pharmaceuticals Inc.
$207
Merck Sharp & Dohme LLC
$183
180 Medical, Inc.
$170
Antares Pharma, Inc.
$165
Blue Earth Diagnostics Limited
$161
PROCEPT BioRobotics Corporation
$143
SN Holdings, LLC
$140
Allergan Inc.
$135
Tolmar, Inc.
$128
Coloplast Corp
$101
Telix Pharmaceuticals
$90
Integra LifeSciences Corporation
$89
UroGen Pharma, Inc.
$88
Janssen Scientific Affairs, LLC
$82
Sun Pharmaceutical Industries Inc.
$79
Amgen Inc.
$76
BOSTON SCIENTIFIC CORPORATION
$66
ACCORD HEALTHCARE, INC.
$62
TOLMAR Pharmaceuticals, Inc.
$61
Olympus America Inc.
$61
Allergan, Inc.
$55
Ferring Pharmaceuticals Inc.
$54
Baxter Healthcare
$54
MEDIVATION FIELD SOLUTIONS LLC
$51
Verity Pharmaceuticals Inc.
$48
Smith+Nephew, Inc.
$46
Foundation Medicine, Inc.
$37
Axonics Modulation Technologies, Inc.
$35
Medtronic, Inc.
$31
AbbVie, Inc.
$31
Boston Scientific Corporation
$30
Rochester Medical Corporation
$25
Photocure Inc
$22
Accord Healthcare, Inc.
$20
COLOPLAST CORP
$20
Pacira Pharmaceuticals Incorporated
$17
Avadel Specialty Pharmaceuticals, LLC
$17
Ethicon US, LLC
$16
Travere Therapeutics, Inc.
$16
Metuchen Pharmaceuticals
$13
DENTSPLY IH Inc.
$13
Acerus Pharmaceuticals Corporation
$12
Cook Medical LLC
$11
Top 3 companies account for 74.4% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AFINITOR · ALTIS · AMS · AQUABEAM SYSTEM · AVEED · AXIS · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CYSVIEW · Cook Medical Holmium Laser Fiber · DA VINCI SP · DURASPHERE · Da Vinci Surgical System · ELIGARD · ERLEADA · EXPAREL · Enseal X1 5mm · Erleada · FOUNDATIONONE · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GREENLIGHT · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · MEDIHONEY · MYRBETRIQ · Myrbetriq · Natesto · Noctiva · Nubeqa · ORGOVYX · PERCLOT · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · Porges Coloplast · Prolaris · Prolia · ReTrace · SOLESTA · STRAVIX · SUTENT · Stendra · Stravix · TISSEEL · TITAN · Trelstar · UROLIFT · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for urology physician in FL.
Equivalent to $281 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
32
Per 100K population
23.3
County median income
$73,297
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
12.2 mi
12.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Karavadia is a clinical cardiology specialist, with above-average Medicare volume (top 7% in FL), with speaking/promotional industry engagement in the top 6% of FL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Karavadia experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Karavadia performed 3,501 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Karavadia receive payments from pharmaceutical companies?
Yes. Dr. Karavadia received a total of $47,763 from 62 companies across 590 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Karavadia's costs compare to other urology physicians in Oxford?
Dr. Karavadia's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Karavadia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Oxford
Browse urology physicians in Oxford ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology